/Companies

AlloMek Therapeutics

Woodbridge, US · Delaware LLC · 1 known investors

Find your way into AlloMek Therapeutics

Sign up to see every warm intro you have to AlloMek Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AlloMek Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Acquired by Pasithea Therapeutics

Founders & leadership

JF
Jason FishermanNamed on SEC filing
DW
Daniel WagnerNamed on SEC filing
UK
Uday KhireNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$1.3M disclosed across 1 round · 2016

▶$1.3MraisedFeb 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason FishermanDirector
  • Daniel WagnerDirector
  • Uday KhireExecutive Officer, Director
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Dec 2016
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does AlloMek Therapeutics do?
Acquired by Pasithea Therapeutics
Who are AlloMek Therapeutics's investors?
AlloMek Therapeutics's investors include Connecticut Innovations.
How much funding has AlloMek Therapeutics raised?
AlloMek Therapeutics has disclosed $1.3M raised across 1 round.
Where is AlloMek Therapeutics headquartered?
AlloMek Therapeutics is headquartered in Woodbridge, US.